KASTHURI SIVAKUMAR: Open Payments
NPI 1093341141 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$768 in 20 payments from 9 companies in 2025. Trend: 2023 $493 · 2024 $679 · 2025 $768
Food & beverage: $768
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $143 |
| Abbott Laboratories | 2 | $134 |
| Novo Nordisk Inc | 1 | $119 |
| E.R. Squibb & Sons, L.L.C. | 2 | $114 |
| Novartis Pharmaceuticals Corporation | 5 | $103 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $75 |
| SCPHARMACEUTICALS INC. | 2 | $37 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $20 |
Products named: CARDIOMEMS, LOKELMA, Wegovy, CAMZYOS, LEQVIO, JARDIANCE, FUROSCIX, VERQUVO.
Industry payments across NY — which companies pay providers there.
